A Living Library: Rare Collection at UF Drives Breakthroughs in Biomedical Discovery
Compiled over the course of 80 years, some of the organisms in this living library collection’s glass vials are likely extinct in the natural world, offering an irreplaceable window into the past. For Ben Shen, PhD, a professor of chemistry and director of the Natural Products Discovery Center, and his research team at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Jupiter, Florida, these unexplored microbes — a treasure trove of biodiversity — hold untold promise for treating disease, providing a tantalizing glimpse into the future of drug discovery.
Yikes! Scientists Discover Factor That Directs Brain’s Fear Conditioning
A team led by neuroscientists at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology has discovered a key molecular player in fear conditioning. It’s a specialized RNA with a memorable acronym, SLAMR. Their study found SLAMR must be present in adequate quantities for neurons to build the complex connections required for fear conditioning. Their research appears in the journal Nature Communications.
Targeting RNA
Disney and his team at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Jupiter, Florida, have discovered more than 200 unique RNA-targeting compounds. His methods and discoveries have changed minds, igniting a global race to treat incurable diseases via their RNA.
Novel ‘Chimera’ Drug Targets the ‘Undruggable’ Parkinson’s Protein
Researchers at The Herbert Wertheim UF Scripps Institute in Jupiter, FL have created a "two-headed" drug nicknamed Chimera due to its ability to target RNA machinery as well as the toxic protein that causes Parkinson's disease.
NIH ‘High Risk-High Reward’ Grants Go to Two UF Health Researchers Exploring Strategies To Fight Cancer and Other Diseases
Two University of Florida Health researchers have received prestigious High Risk-High Reward grants from the National Institutes of Health’s Common Fund for their trailblazing proposals to tackle cancer and other diseases, the NIH announced.
Third Annual Science2Startup Symposium Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors
Kirill Martemyanov, Ph.D., professor and chair of The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, is one of the 10 presenters selected for the third annual Science2Startup Symposium taking place May 3, 2023.
